Literature DB >> 25345568

Differential effects of lipopolysaccharide on energy metabolism in murine microglial N9 and cholinergic SN56 neuronal cells.

Joanna Klimaszewska-Łata1, Sylwia Gul-Hinc, Hanna Bielarczyk, Anna Ronowska, Marlena Zyśk, Katarzyna Grużewska, Tadeusz Pawełczyk, Andrzej Szutowicz.   

Abstract

There are significant differences between acetyl-CoA and ATP levels, enzymes of acetyl-CoA metabolism, and toll-like receptor 4 contents in non-activated microglial N9 and non-differentiated cholinergic SN56 neuroblastoma cells. Exposition of N9 cells to lipopolysaccharide caused concentration-dependent several-fold increases of nitrogen oxide synthesis, accompanied by inhibition of pyruvate dehydrogenase complex, aconitase, and α-ketoglutarate dehydrogenase complex activities, and by nearly proportional depletion of acetyl-CoA, but by relatively smaller losses in ATP content and cell viability (about 5%). On the contrary, SN56 cells appeared to be insensitive to direct exposition to high concentration of lipopolysaccharide. However, exogenous nitric oxide resulted in marked inhibition pyruvate dehydrogenase and aconitase activities, depletion of acetyl-CoA, along with respective loss of SN56 cells viability. These data indicate that these two common neurodegenerative signals may differentially affect energy-acetyl-CoA metabolism in microglial and cholinergic neuronal cell compartments in the brain. Moreover, microglial cells appeared to be more resistant than neuronal cells to acetyl-CoA and ATP depletion evoked by these neurodegenerative conditions. Together, these data indicate that differential susceptibility of microglia and cholinergic neuronal cells to neurotoxic signals may result from differences in densities of toll-like receptors and degree of disequilibrium between acetyl-CoA provision in mitochondria and its utilization for energy production and acetylation reactions in each particular group of cells. There are significant differences between acetyl-CoA and ATP levels and enzymes of acetyl-CoA metabolism in non-activated microglial N9 and non-differentiated cholinergic SN56 neuroblastoma cells. Pathological stimulation of microglial toll-like receptors (TLRs) triggered excessive synthesis of microglia-derived nitric oxide (NO)/NOO radicals that endogenously inhibited pyruvate dehydrogenase complex (PDHC), aconitase, and α-ketoglutarate dehydrogenase complex. However, it caused none or small suppressions of acetyl-CoA and microglial viability, respectively. Microglia-derived NO inhibited same enzymes in cholinergic neuronal cells causing marked viability loss because of acetyl-CoA deficits evoked by its competitive consumption by energy producing and acetylcholine/N-acetyl-l-aspartate (NAA) synthesizing pathways.
© 2014 International Society for Neurochemistry.

Entities:  

Keywords:  N9 cells; NO; SN56 cells; acetyl-CoA; cytotoxicity; lipopolysaccharide

Mesh:

Substances:

Year:  2015        PMID: 25345568     DOI: 10.1111/jnc.12979

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

Review 1.  Microglial M1/M2 polarization and metabolic states.

Authors:  Ruben Orihuela; Christopher A McPherson; Gaylia Jean Harry
Journal:  Br J Pharmacol       Date:  2015-05-11       Impact factor: 8.739

2.  Hyperpolarized 13 C magnetic resonance spectroscopy detects toxin-induced neuroinflammation in mice.

Authors:  Lydia M Le Page; Caroline Guglielmetti; Chloé F Najac; Brice Tiret; Myriam M Chaumeil
Journal:  NMR Biomed       Date:  2019-08-22       Impact factor: 4.044

Review 3.  Metabolic and Cellular Compartments of Acetyl-CoA in the Healthy and Diseased Brain.

Authors:  Agnieszka Jankowska-Kulawy; Joanna Klimaszewska-Łata; Sylwia Gul-Hinc; Anna Ronowska; Andrzej Szutowicz
Journal:  Int J Mol Sci       Date:  2022-09-03       Impact factor: 6.208

Review 4.  Microglia and macrophage metabolism in CNS injury and disease: The role of immunometabolism in neurodegeneration and neurotrauma.

Authors:  Nicholas A Devanney; Andrew N Stewart; John C Gensel
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

5.  Gas chromatography-time of flight/mass spectrometry-based metabonomics of changes in the urinary metabolic profile in osteoarthritic rats.

Authors:  Hui Jiang; Jian Liu; Xiu-Juan Qin; Yuan-Yuan Chen; Jia-Rong Gao; Mei Meng; Yuan Wang; Ting Wang
Journal:  Exp Ther Med       Date:  2018-01-24       Impact factor: 2.447

Review 6.  Early and Late Pathomechanisms in Alzheimer's Disease: From Zinc to Amyloid-β Neurotoxicity.

Authors:  Andrzej Szutowicz; Hanna Bielarczyk; Marlena Zyśk; Aleksandra Dyś; Anna Ronowska; Sylwia Gul-Hinc; Joanna Klimaszewska-Łata
Journal:  Neurochem Res       Date:  2016-12-30       Impact factor: 3.996

Review 7.  The Regulatory Effects of Acetyl-CoA Distribution in the Healthy and Diseased Brain.

Authors:  Anna Ronowska; Andrzej Szutowicz; Hanna Bielarczyk; Sylwia Gul-Hinc; Joanna Klimaszewska-Łata; Aleksandra Dyś; Marlena Zyśk; Agnieszka Jankowska-Kulawy
Journal:  Front Cell Neurosci       Date:  2018-07-10       Impact factor: 5.505

8.  Metabolic Connection of Inflammatory Pain: Pivotal Role of a Pyruvate Dehydrogenase Kinase-Pyruvate Dehydrogenase-Lactic Acid Axis.

Authors:  Mithilesh Kumar Jha; Gyun Jee Song; Maan Gee Lee; Nam Ho Jeoung; Younghoon Go; Robert A Harris; Dong Ho Park; Hyun Kook; In-Kyu Lee; Kyoungho Suk
Journal:  J Neurosci       Date:  2015-10-21       Impact factor: 6.167

9.  The Effects of Sodium Dichloroacetate on Mitochondrial Dysfunction and Neuronal Death Following Hypoglycemia-Induced Injury.

Authors:  A Ra Kho; Bo Young Choi; Song Hee Lee; Dae Ki Hong; Jeong Hyun Jeong; Beom Seok Kang; Dong Hyeon Kang; Kyoung-Ha Park; Jae Bong Park; Sang Won Suh
Journal:  Cells       Date:  2019-05-01       Impact factor: 6.600

Review 10.  Mitochondria, Microglia, and the Immune System-How Are They Linked in Affective Disorders?

Authors:  Carsten Culmsee; Susanne Michels; Stefanie Scheu; Volker Arolt; Udo Dannlowski; Judith Alferink
Journal:  Front Psychiatry       Date:  2019-01-09       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.